Followers | 44 |
Posts | 3243 |
Boards Moderated | 2 |
Alias Born | 01/18/2016 |
Wednesday, December 28, 2022 4:26:50 PM
In addition to the Ph-Neutral formulation of Furoscix, FDA has approved the use of an automatic infusor for administration of the prescribed dosage.
Furoscix enables subcutaneous administration at home by the patient or a caregiver with the use of the On-Body Infusor, which was developed using West Pharmaceutical Services SmartDose technology. Once the pre-filled cartridge is inserted into the pre-programmed infusor and attached to the abdomen, the device is activated to deliver the 80-mg dose over five hours.
https://clinicaltrials.gov/ct2/show/NCT03458325
https://www.empr.com/home/news/fda-approves-wearable-furosemide-delivery-system-furoscix-for-outpatient-use/
Recent SCPH News
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 08/28/2024 08:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:09:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:01:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:58:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 12:03:43 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/12/2024 10:48:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 10:08:00 AM
- scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors • GlobeNewswire Inc. • 08/12/2024 10:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:15:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:06:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:06:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:20:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:07:07 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 05:35:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 01:28:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:30:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:48:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:23:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:05:54 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM